Biologics in the treatment of primary inflammatory myositis.
Wendling
Daniel
D
D001688:Biological Products / Q000627:therapeutic use*; D001707:Biopsy, Needle; D003882:Dermatomyositis / Q000188:drug therapy / Q000473:pathology; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D018836:Inflammation Mediators / Q000032:analysis; D008297:Male; D009220:Myositis / Q000473:pathology* / Q000628:therapy*; D018979:Myositis, Inclusion Body; D017285:Polymyositis / Q000188:drug therapy / Q000473:pathology; D011379:Prognosis; D018570:Risk Assessment; D016896:Treatment Outcome
D001688:Biological Products; D018836:Inflammation Mediators